| scholarly article | Q13442814 |
| P50 | author | Yixun Geng | Q125271120 |
| Shuohao Sun | Q125271143 | ||
| Vineeta Tiwari | Q125271150 | ||
| Pang-Yen Tseng | Q125271202 | ||
| ??? | Q16075062 | ||
| P2093 | author name string | Yan Wang | |
| Junmin Peng | |||
| Qian Xu | |||
| Bo Xiao | |||
| Srinivasa N Raja | |||
| Zhe Li | |||
| Liang Han | |||
| Zhiping Wu | |||
| Qin Zheng | |||
| Anna L Blobaum | |||
| Shao-Qiu He | |||
| Vinod Tiwari | |||
| Yun Guan | |||
| Yingying Cheng | |||
| Yiyuan Cui | |||
| Corey Hopkins | |||
| Julie H Y Huang-Lionnet | |||
| P2860 | cites work | Direct interaction of gbetagamma with a C-terminal gbetagamma-binding domain of the Ca2+ channel alpha1 subunit is responsible for channel inhibition by G protein-coupled receptors | Q24647488 |
| Atypical expansion in mice of the sensory neuron-specific Mrg G protein-coupled receptor family | Q24681230 | ||
| Structure and regulation of voltage-gated Ca2+ channels | Q28141138 | ||
| Can we conquer pain? | Q28211527 | ||
| A diverse family of GPCRs expressed in specific subsets of nociceptive sensory neurons | Q28215950 | ||
| RNA-Seq Analysis of Human Trigeminal and Dorsal Root Ganglia with a Focus on Chemoreceptors | Q28548290 | ||
| Cellular and Molecular Mechanisms of Pain | Q29011961 | ||
| Neuronal plasticity: increasing the gain in pain | Q29615421 | ||
| Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment | Q30458126 | ||
| A subpopulation of nociceptors specifically linked to itch | Q30533337 | ||
| Proenkephalin A gene products activate a new family of sensory neuron--specific GPCRs | Q30674748 | ||
| Identification of small molecule antagonists of the human mas-related gene-X1 receptor | Q33235164 | ||
| The G protein-coupled receptor subset of the rat genome | Q33300185 | ||
| Multiple G-protein-coupled pathways inhibit N-type Ca channels of neurons. | Q33585453 | ||
| A partial L5 spinal nerve ligation induces a limited prolongation of mechanical allodynia in rats: an efficient model for studying mechanisms of neuropathic pain | Q33687360 | ||
| Activation of MrgC receptor inhibits N-type calcium channels in small-diameter primary sensory neurons in mice | Q33923266 | ||
| Mas-related G-protein–coupled receptors inhibit pathological pain in mice | Q34115658 | ||
| Central sensitization and LTP: do pain and memory share similar mechanisms? | Q34277624 | ||
| A new family of endogenous "big" Met-enkephalins from bovine adrenal medulla: purification and structure of docosa- (BAM-22P) and eicosapeptide (BAM-20P) with very potent opiate activity | Q34281783 | ||
| Orphan G protein-coupled receptors MrgA1 and MrgC11 are distinctively activated by RF-amide-related peptides through the Galpha q/11 pathway | Q34379315 | ||
| Alternative splicing controls G protein-dependent inhibition of N-type calcium channels in nociceptors | Q34523190 | ||
| Expression of voltage-gated calcium channel subunits in rat dorsal root ganglion neurons | Q74541205 | ||
| Ziconotide--a novel neuron-specific calcium channel blocker for the intrathecal treatment of severe chronic pain--a short review. | Q34576511 | ||
| A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor | Q34708055 | ||
| Discovery and characterization of 2-(cyclopropanesulfonamido)-N-(2-ethoxyphenyl)benzamide, ML382: a potent and selective positive allosteric modulator of MrgX1. | Q34772357 | ||
| BAM8-22 peptide produces itch and nociceptive sensations in humans independent of histamine release | Q35034301 | ||
| The inhibition of high-voltage-activated calcium current by activation of MrgC11 involves phospholipase C-dependent mechanisms | Q35798251 | ||
| Voltage-gated calcium channels as targets for the treatment of chronic pain | Q35972024 | ||
| Unmasking the tonic-aversive state in neuropathic pain | Q36189364 | ||
| Ziconotide, an intrathecally administered N-type calcium channel antagonist for the treatment of chronic pain | Q36277918 | ||
| Mechanisms of itch evoked by β-alanine | Q36378701 | ||
| The role of voltage-gated calcium channels in pain and nociception | Q36671578 | ||
| Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders | Q37360436 | ||
| Block of calcium channels by enkephalin and somatostatin in neuroblastoma-glioma hybrid NG108-15 cells | Q37413178 | ||
| Targeting voltage-gated calcium channels for neuropathic pain management | Q37605352 | ||
| MrgC agonism at central terminals of primary sensory neurons inhibits neuropathic pain | Q37622078 | ||
| Temporal changes in MrgC expression after spinal nerve injury | Q37622877 | ||
| Determinants of the G protein-dependent opioid modulation of neuronal calcium channels | Q37718351 | ||
| What is spontaneous pain and who has it? | Q38028722 | ||
| Evaluation of reward from pain relief | Q38089905 | ||
| A systematic review: current and future directions of dorsal root ganglion therapeutics to treat chronic pain | Q38117183 | ||
| Calcium-permeable ion channels in pain signaling | Q38175134 | ||
| Sensory neuron-specific MAS-related gene-X1 receptors resist agonist-promoted endocytosis | Q38344494 | ||
| Characterization of the Mas-related gene family: structural and functional conservation of human and rhesus MrgX receptors | Q38738222 | ||
| Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial | Q39386029 | ||
| Adaptive Evolution of MRG, a Neuron-Specific Gene Family Implicated in Nociception | Q40829986 | ||
| Opioid therapy for chronic nonmalignant pain: a review of the critical issues | Q40943421 | ||
| Modulation of Ca2+ channels by G-protein beta gamma subunits | Q41214714 | ||
| Sensory neuron-specific GPCR Mrgprs are itch receptors mediating chloroquine-induced pruritus | Q41686577 | ||
| Kinetic and pharmacological properties distinguishing three types of calcium currents in chick sensory neurones | Q41820930 | ||
| Effect of Mas-related gene (Mrg) receptors on hyperalgesia in rats with CFA-induced inflammation via direct and indirect mechanisms | Q42062642 | ||
| Dynorphin A decreases voltage-dependent calcium conductance of mouse dorsal root ganglion neurones | Q43978577 | ||
| Ca2+ channel inhibition by kappa opioid receptors expressed in Xenopus oocytes. | Q44332960 | ||
| mu-Opioid receptor-mediated reduction of neuronal calcium current occurs via a G(o)-type GTP-binding protein | Q44338763 | ||
| The GTP-binding protein, Go, regulates neuronal calcium channels | Q44508440 | ||
| Intrathecal, but not intravenous adenosine reduces allodynia in patients with neuropathic pain | Q44589931 | ||
| Effect of chronic administration of morphine on the expression of bovine adrenal medulla 22-like immunoreactivity in the spinal cord of rats | Q46520803 | ||
| Modulation of ion channels and synaptic transmission by a human sensory neuron-specific G-protein-coupled receptor, SNSR4/mrgX1, heterologously expressed in cultured rat neurons. | Q47428149 | ||
| Cyclic dimers of C-terminal gamma2-MSH analogs as selective antagonists of the human sensory nerve-specific receptor (SNSR-4). | Q47926005 | ||
| Cloning and expression of MRG receptors in macaque, mouse, and human | Q49050477 | ||
| Differences in Ca2+ channels governing generation of miniature and evoked excitatory synaptic currents in spinal laminae I and II. | Q51496112 | ||
| The involvement of spinal bovine adrenal medulla 22-like peptide, the proenkephalin derivative, in modulation of nociceptive processing. | Q53530664 | ||
| Distinct mechanisms underlying pronociceptive effects of opioids. | Q53690404 | ||
| Dynorphin A-mediated reduction in multiple calcium currents involves a G(o) alpha-subtype G protein in rat primary afferent neurons | Q73185709 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | G protein-coupled receptor | Q38173 |
| P304 | page(s) | E1996-E2005 | |
| P577 | publication date | 2017-02-21 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Targeting human Mas-related G protein-coupled receptor X1 to inhibit persistent pain | |
| P478 | volume | 114 |
| Q92215124 | BAM8-22 and its receptor MRGPRX1 may attribute to cholestatic pruritus |
| Q47246872 | Cellular and molecular mechanisms driving neuropathic pain: recent advancements and challenges |
| Q58104642 | Demethylation of G protein-coupled receptor 151 promoter facilitates the binding of Kruppel-like factor 5 and enhances neuropathic pain after nerve injury in mice |
| Q60907595 | From Synapse to Function: A Perspective on the Role of Neuroproteomics in Elucidating Mechanisms of Drug Addiction |
| Q55465669 | Involvement of MrgprC in Electroacupuncture Analgesia for Attenuating CFA-Induced Thermal Hyperalgesia by Suppressing the TRPV1 Pathway. |
| Q64117147 | Nppb Neurons Are Sensors of Mast Cell-Induced Itch |
| Q64944700 | Oligomerization of MrgC11 and μ-opioid receptors in sensory neurons enhances morphine analgesia. |
| Q53422317 | Peripherally Acting μ-Opioid Receptor Agonists Attenuate Ongoing Pain-associated Behavior and Spontaneous Neuronal Activity after Nerve Injury in Rats. |
Search more.